OU Health University of Oklahoma Medical Center ( Site 7000)

Oklahoma City, Oklahoma 73104

1 studies enrolling now · 1 studies all time

What they study most

Ovarian Cancer Recurrent

Studies at this site

• A Clinical Study of Raludotatug Deruxtecan in People With Ovarian Cancer (MK-5909-003) — Recruiting now